- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Kepler Vision spots UvA Ventures in $2.1m round
University of Amsterdam-founded Kepler Vision has secured capital from investors including UvA Ventures to commercialise body language recognition products.
Mar 31, 2018Symbiotix secures Harvard licences
Symbiotix has licensed more Harvard IP to propel the commercialisation of T-cell modulators based on studies of the human microbiome.
Mar 29, 2018Circular Wave coils together $2m seed round
The Ohio State spinout raised an additional $900,000 to advance its speed control gear technology for industrial robots.
Mar 29, 2018Metalysis casts $17m round
Several existing shareholders including Woodford have returned to back a $17m funding round for Metalysis, which produces metal powders for 3D printing.
Mar 29, 2018Vanderbilt to benefit from $65m partnership
Deerfield Management and Vanderbilt University have launched Ancora Innovation with $65m in capital to support early-stage life science research and back resulting spinouts.
Mar 29, 2018CTT touches on Parkwalk investment
Parkwalk has invested from two vehicles under its management after previously backing the Cambridge spinout in late 2016.
Mar 28, 2018Axcend arises out of BYU
Axcend hoppes to release a portable liquid chromatograph that has a high sensitivity and is compatible with various web-enabled devices.
Mar 27, 2018Myriota orbits $15m series A
Nanosatellite internet of things technology developer Myriota has attracted $15m in series A funding from investors co-led by Main Sequence Ventures.
Mar 27, 2018Big deal: NMD flexes series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
Mar 26, 2018Dracen collects $40m series A
The Johns Hopkins spinout will funnel the cash into developing a class of glutamine antagonist that could help treat cancer.
Mar 26, 2018Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


